These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
291 related articles for article (PubMed ID: 22134880)
21. IgA nephropathy: an update. Soares MF; Roberts IS Curr Opin Nephrol Hypertens; 2017 May; 26(3):165-171. PubMed ID: 28221174 [TBL] [Abstract][Full Text] [Related]
22. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. ; Cattran DC; Coppo R; Cook HT; Feehally J; Roberts IS; Troyanov S; Alpers CE; Amore A; Barratt J; Berthoux F; Bonsib S; Bruijn JA; D'Agati V; D'Amico G; Emancipator S; Emma F; Ferrario F; Fervenza FC; Florquin S; Fogo A; Geddes CC; Groene HJ; Haas M; Herzenberg AM; Hill PA; Hogg RJ; Hsu SI; Jennette JC; Joh K; Julian BA; Kawamura T; Lai FM; Leung CB; Li LS; Li PK; Liu ZH; Mackinnon B; Mezzano S; Schena FP; Tomino Y; Walker PD; Wang H; Weening JJ; Yoshikawa N; Zhang H Kidney Int; 2009 Sep; 76(5):534-45. PubMed ID: 19571791 [TBL] [Abstract][Full Text] [Related]
23. The Oxford Classification predictors of chronic kidney disease in pediatric patients with IgA nephropathy. Fabiano RCG; Araújo SA; Bambirra EA; Oliveira EA; Simões E Silva AC; Pinheiro SVB J Pediatr (Rio J); 2017; 93(4):389-397. PubMed ID: 28130969 [TBL] [Abstract][Full Text] [Related]
24. Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Shi SF; Wang SX; Jiang L; Lv JC; Liu LJ; Chen YQ; Zhu SN; Liu G; Zou WZ; Zhang H; Wang HY Clin J Am Soc Nephrol; 2011 Sep; 6(9):2175-84. PubMed ID: 21852672 [TBL] [Abstract][Full Text] [Related]
25. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update. Coppo R; D'Arrigo G; Tripepi G; Russo ML; Roberts ISD; Bellur S; Cattran D; Cook TH; Feehally J; Tesar V; Maixnerova D; Peruzzi L; Amore A; Lundberg S; Di Palma AM; Gesualdo L; Emma F; Rollino C; Praga M; Biancone L; Pani A; Feriozzi S; Polci R; Barratt J; Del Vecchio L; Locatelli F; Pierucci A; Caliskan Y; Perkowska-Ptasinska A; Durlik M; Moggia E; Ballarin JC; Wetzels JFM; Goumenos D; Papasotiriou M; Galesic K; Toric L; Papagianni A; Stangou M; Benozzi L; Cusinato S; Berg U; Topaloglu R; Maggio M; Ots-Rosenberg M; D'Amico M; Geddes C; Balafa O; Quaglia M; Cravero R; Lino Cirami C; Fellstrom B; Floege J; Egido J; Mallamaci F; Zoccali C; Nephrol Dial Transplant; 2020 Jun; 35(6):1002-1009. PubMed ID: 30418652 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Lv J; Shi S; Xu D; Zhang H; Troyanov S; Cattran DC; Wang H Am J Kidney Dis; 2013 Nov; 62(5):891-9. PubMed ID: 23820066 [TBL] [Abstract][Full Text] [Related]
27. Podocyte injury as a potential therapeutic target in IgA nephropathy: should pathology guide us? Haas M Kidney Int; 2024 Jun; 105(6):1165-1167. PubMed ID: 38777401 [TBL] [Abstract][Full Text] [Related]
28. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences. Riispere Ž; Laurinavičius A; Kuudeberg A; Seppet E; Sepp K; Ilmoja M; Luman M; Kõlvald K; Auerbach A; Ots-Rosenberg M Medicina (Kaunas); 2016; 52(6):340-348. PubMed ID: 27932191 [TBL] [Abstract][Full Text] [Related]
29. Location of glomerular immune deposits, not codeposition of immunoglobulin G, influences definitive renal outcomes in immunoglobulin A nephropathy. Alvarado AS; Andeen NK; Brodsky S; Hinton A; Nadasdy T; Alpers CE; Blosser C; Najafian B; Rovin BH Nephrol Dial Transplant; 2018 Jul; 33(7):1168-1175. PubMed ID: 28992348 [TBL] [Abstract][Full Text] [Related]
30. Immunostaining findings in IgA nephropathy: correlation with histology and clinical outcome in the Oxford classification patient cohort. Bellur SS; Troyanov S; Cook HT; Roberts IS; Nephrol Dial Transplant; 2011 Aug; 26(8):2533-6. PubMed ID: 21273233 [TBL] [Abstract][Full Text] [Related]
31. Usefulness of Oxford classification in assessing immunoglobulin A nephropathy after transplantation. Lim BJ; Joo DJ; Kim MS; Kim YS; Kim SI; Kim Y; Huh KH; Koh MJ; Jeong HJ Transplantation; 2013 Jun; 95(12):1491-7. PubMed ID: 23677050 [TBL] [Abstract][Full Text] [Related]
32. Reproducibility for pathological prognostic parameters of the Oxford classification of IgA nephropathy: a Japanese cohort study of the Ministry of Health, Labor and Welfare. Hisano S; Joh K; Katafuchi R; Shimizu A; Hashiguchi N; Kawamura T; Matsuo S; Clin Exp Nephrol; 2017 Feb; 21(1):92-96. PubMed ID: 27011013 [TBL] [Abstract][Full Text] [Related]
33. Pathology of IgA nephropathy. Roberts IS Nat Rev Nephrol; 2014 Aug; 10(8):445-54. PubMed ID: 24861083 [TBL] [Abstract][Full Text] [Related]
34. The Oxford classification of IgA nephropathy: single centre experience. Grcevska L; Ristovska V; Nikolov V; Petrusevska G; Milovanceva-Popovska M; Polenakovic M Prilozi; 2010; 31(2):7-16. PubMed ID: 21258273 [TBL] [Abstract][Full Text] [Related]
35. 30-year follow-up study of IgA nephritis in a Southeast Asian population: an evaluation of the Oxford histological classification . Woo KT; Lim CC; Foo MW; Loh HL; Jin AZ; Chin YM; Choo JC; Tan PH; Chow KY; Choong LH; Tan HK; Wong KS; Chan CM Clin Nephrol; 2016 Nov; 86 (2016)(11):270-278. PubMed ID: 27641054 [TBL] [Abstract][Full Text] [Related]
36. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: evidence from the VALidation of IGA study cohort. Bellur SS; Roberts ISD; Troyanov S; Royal V; Coppo R; Cook HT; Cattran D; Arce Terroba Y; Asunis AM; Bajema I; Bertoni E; Bruijn JA; Cannata-Ortiz P; Casartelli D; Maria Di Palma A; Ferrario F; Fortunato M; Furci L; Gakiopoulou H; Galesic Ljubanovic D; Giannakakis K; Gomà M; Gröne HJ; Gutiérrez E; Asma Haider S; Honsova E; Ioachim E; Karkoszka H; Kipgen D; Maldyk J; Mazzucco G; Orhan D; Ozluk Y; Pantzaki A; Perkowska-Ptasinska A; Riispere Z; Soderberg MP; Steenbergen E; Stoppacciaro A; Sundelin Von Feilitzen B; Tardanico R Nephrol Dial Transplant; 2019 Oct; 34(10):1681-1690. PubMed ID: 30561721 [TBL] [Abstract][Full Text] [Related]
37. Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification. Hirano K; Amano H; Kawamura T; Watanabe K; Koike K; Shimizu A; Endo S; Tsuboi N; Okonogi H; Miyazaki Y; Ikeda M; Hanaoka K; Ogura M; Komatsumoto S; Yokoo T Clin Exp Nephrol; 2016 Jun; 20(3):425-32. PubMed ID: 26415960 [TBL] [Abstract][Full Text] [Related]
38. Relationship between complement deposition and the Oxford classification score and their combined effects on renal outcome in immunoglobulin A nephropathy. Park S; Kim HW; Park JT; Chang TI; Kang EW; Ryu DR; Yoo TH; Chin HJ; Jeong HJ; Kang SW; Lim BJ; Han SH Nephrol Dial Transplant; 2020 Dec; 35(12):2103-2137. PubMed ID: 31377783 [TBL] [Abstract][Full Text] [Related]
39. Clinical and histological differences between adults and children in new onset IgA nephropathy. Cambier A; Rabant M; El Karoui K; Peuchmaur M; Servais A; Hertig A; Deschenes G; Salomon R; Hogan J; Robert T Pediatr Nephrol; 2020 Oct; 35(10):1897-1905. PubMed ID: 32444925 [TBL] [Abstract][Full Text] [Related]
40. Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schönlein purpura nephritis in adults. Kim CH; Lim BJ; Bae YS; Kwon YE; Kim YL; Nam KH; Park KS; An SY; Koo HM; Doh FM; Lee MJ; Oh HJ; Yoo TH; Kang SW; Choi KH; Jeong HJ; Han SH Mod Pathol; 2014 Jul; 27(7):972-82. PubMed ID: 24390221 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]